Jaime Libes1, Oliver Oruko2, Fatmah Abdallah3, Jessie Githanga3, James Ndung'u4, Joyce Musimbi5, Festus Njuguna5, Kirtika Patel6, John White7, Jason R Axt8, James A O'Neill8, Martha Shrubsole7, Ming Li9, Harold N Lovvorn8. 1. Department of Pediatrics, Vanderbilt University Children's Hospital, Nashville, Tennessee. 2. Department of Human Pathology, University of Nairobi, Nairobi, Kenya. 3. Department of Haematology and Blood Transfusion, University of Nairobi, Nairobi, Kenya. 4. Department of Surgery, Kenyatta National Hospital, Nairobi, Kenya. 5. USAID-Ampath Partnership, Moi Teaching and Referral Hospital, Eldoret, Kenya. 6. Department of Immunology, Moi Teaching and Referral Hospital, Eldoret, Kenya. 7. Vanderbilt Epidemiology Center, Vanderbilt Institute for Medicine and Public Health, Nashville, Tennessee. 8. Department of Pediatric Surgery, Vanderbilt University Children's Hospital, Nashville, Tennessee. 9. Department of Biostatistics, Vanderbilt University Children's Hospital, Nashville, Tennessee.
Abstract
BACKGROUND: Survival from Wilms tumor (WT) in sub-Saharan Africa remains dismal as a result of on-therapy mortality and treatment abandonment. Review of patients diagnosed from 2008 to 2011 in our Kenyan Wilms Tumor Registry showed a loss to follow up (LTFU) rate approaching 50%. The purpose of this study was to trace those LTFU, estimate the survival rate, and identify risk factors for treatment abandonment. PROCEDURE: We administered a comprehensive survey to parents of patients with WT at the two largest referral hospitals in Kenya to identify barriers to care. We also telephoned families who had abandoned care to determine vital status and identify risk factors for treatment abandonment. RESULTS: Of 136 registered patients, 77 were confirmed dead (56.7%), 38 remained alive (27.9%), and the vital status of 21 patients remains unknown (15.4%). After contacting 33 of the patients who either abandoned curative treatment (n = 34) or did not attend off-therapy visits (n = 20), the best estimate of 2-year overall survival of patients with WT in Kenya approaches 36%. Sixty-three percent of parents misunderstood treatment plans and 55% encountered financial barriers. When asked how to increase comfort with the child's treatment, 27% of parents volunteered improving inefficient services and 26% volunteered reducing drug-unavailability. CONCLUSIONS: Treatment abandonment remains a significant problem contributing to increased mortality from WT in developing countries. This multi-center survey identified the barriers to treatment completion from the parental perspective to be lack of education about WT and treatment, financial constraints, need for quality improvement, and drug-unavailability. Pediatr Blood Cancer 2015;62:252-256.
BACKGROUND: Survival from Wilms tumor (WT) in sub-Saharan Africa remains dismal as a result of on-therapy mortality and treatment abandonment. Review of patients diagnosed from 2008 to 2011 in our Kenyan Wilms Tumor Registry showed a loss to follow up (LTFU) rate approaching 50%. The purpose of this study was to trace those LTFU, estimate the survival rate, and identify risk factors for treatment abandonment. PROCEDURE: We administered a comprehensive survey to parents of patients with WT at the two largest referral hospitals in Kenya to identify barriers to care. We also telephoned families who had abandoned care to determine vital status and identify risk factors for treatment abandonment. RESULTS: Of 136 registered patients, 77 were confirmed dead (56.7%), 38 remained alive (27.9%), and the vital status of 21 patients remains unknown (15.4%). After contacting 33 of the patients who either abandoned curative treatment (n = 34) or did not attend off-therapy visits (n = 20), the best estimate of 2-year overall survival of patients with WT in Kenya approaches 36%. Sixty-three percent of parents misunderstood treatment plans and 55% encountered financial barriers. When asked how to increase comfort with the child's treatment, 27% of parents volunteered improving inefficient services and 26% volunteered reducing drug-unavailability. CONCLUSIONS: Treatment abandonment remains a significant problem contributing to increased mortality from WT in developing countries. This multi-center survey identified the barriers to treatment completion from the parental perspective to be lack of education about WT and treatment, financial constraints, need for quality improvement, and drug-unavailability. Pediatr Blood Cancer 2015;62:252-256.
Authors: Jason Axt; Fatmah Abdallah; Meridith Axt; Jessie Githanga; Erik Hansen; Joel Lessan; Ming Li; Joyce Musimbi; Michael Mwachiro; Mark Newton; James Ndung'u; Festis Njuguna; Ancent Nzioka; Oliver Oruko; Kirtika Patel; Robert Tenge; Flora Ukoli; Russel White; James A O'Neill; Harold N Lovvorn Journal: J Pediatr Surg Date: 2013-06 Impact factor: 2.545
Authors: Jeffrey S Dome; Conrad V Fernandez; Elizabeth A Mullen; John A Kalapurakal; James I Geller; Vicki Huff; Eric J Gratias; David B Dix; Peter F Ehrlich; Geetika Khanna; Marcio H Malogolowkin; James R Anderson; Arlene Naranjo; Elizabeth J Perlman Journal: Pediatr Blood Cancer Date: 2012-12-19 Impact factor: 3.167
Authors: Dafalla O Abuidris; Mohammed E Elimam; Faisal M Nugud; Elgaili M Elgaili; Mohamed E Ahmed; Ramandeep S Arora Journal: Pediatr Blood Cancer Date: 2008-06 Impact factor: 3.167
Authors: Trijn Israëls; Joyce Kambugu; Francine Kouya; Nader Kim El-Mallawany; Peter B Hesseling; Gertjan J L Kaspers; Tim Eden; Lorna Renner; Elizabeth M Molyneux Journal: Nat Rev Clin Oncol Date: 2013-07-30 Impact factor: 66.675
Authors: Shona Horter; Beverley Stringer; Lucy Reynolds; Muhammad Shoaib; Samuel Kasozi; Esther C Casas; Meggy Verputten; Philipp du Cros Journal: BMC Health Serv Res Date: 2014-02-21 Impact factor: 2.655
Authors: K Ford; S Gunawardana; E Manirambona; G S Philipoh; B Mukama; A Kanyamuhunga; P Cartledge; M J Nyoni; D Mwaipaya; J Mpwaga; Z Bokhary; T Scanlan; T Heinsohn; H Hathaway; R Mansfield; S Wilson; K Lakhoo Journal: World J Surg Date: 2020-01 Impact factor: 3.352
Authors: Harold N Lovvorn; Janene Pierce; Jaime Libes; Bingshan Li; Qiang Wei; Hernan Correa; Julia Gouffon; Peter E Clark; Jason R Axt; Erik Hansen; Mark Newton; James A O'Neill Journal: Genes Chromosomes Cancer Date: 2015-08-14 Impact factor: 5.006
Authors: Paola Friedrich; Catherine G Lam; Elena Itriago; Rafael Perez; Raul C Ribeiro; Ramandeep S Arora Journal: PLoS One Date: 2015-09-30 Impact factor: 3.240
Authors: Paola Friedrich; Catherine G Lam; Geetinder Kaur; Elena Itriago; Raul C Ribeiro; Ramandeep S Arora Journal: PLoS One Date: 2016-10-13 Impact factor: 3.240
Authors: Festus Njuguna; Hugo A Martijn; Robert Tenge Kuremu; Peter Saula; Patel Kirtika; Gilbert Olbara; Sandra Langat; Steve Martin; Jodi Skiles; Terry Vik; Gertjan J L Kaspers; Saskia Mostert Journal: J Glob Oncol Date: 2016-12-21
Authors: Bui Ngoc Lan; Anders Castor; Thomas Wiebe; Jacek Toporski; Christian Moëll; Lars Hagander Journal: BMJ Open Date: 2019-08-05 Impact factor: 2.692